Taiwan FDA registration c17806590a3466e33392e4e09a522674

"Feidiya" Hailon intra-articular injection

TW: “飛荻雅”海隆關節腔注射劑

Taiwan·Risk Class 3·FIDIA FARMACEUTICI S.P.A.·Registered Dec 21, 2022 – Dec 21, 2027Active

Registration details

Analysis ID: c17806590a3466e33392e4e09a522674
Customs Code: DHA05603594808

Company information

Manufacturer: FIDIA FARMACEUTICI S.P.A.
Manufacturer Country: Italy
Authorized Representative: VIGOROUS PHARMA CO., LTD.

Product details

Intended Use: Treatment of pain and improvement of joint function in patients affected by degenerative or mechanical arthritis of the hip and knee joints. This product is indicated for use after persistent pain after initial treatment with analgesics or when non-steroidal anti-inflammatory drugs have failed or are not tolerated.
Product Type (Level 1): N Orthopedics
Product Type (Level 2): N.0003 關節腔玻尿酸植入物
Import Information: import

Dates and status

Registration Date: Dec 21, 2022
Expiry Date: Dec 21, 2027

About this record

Access comprehensive regulatory information for "Feidiya" Hailon intra-articular injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number c17806590a3466e33392e4e09a522674 and manufactured by FIDIA FARMACEUTICI S.P.A.. The authorized representative in Taiwan is VIGOROUS PHARMA CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.